SB-249417

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSB-249417
Drug Alias NameSB-249417
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCoagulation factor IX inhibitors
TargetsCoagulation factor IX
Therapy Area/IndicationsThrombosisStrokeShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsThrombosisStrokeShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A